GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Veerhealth Care Ltd (BOM:511523) » Definitions » EV-to-EBITDA

Veerhealth Care (BOM:511523) EV-to-EBITDA : 16.42 (As of Jun. 02, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Veerhealth Care EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Veerhealth Care's enterprise value is ₹291.8 Mil. Veerhealth Care's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was ₹17.8 Mil. Therefore, Veerhealth Care's EV-to-EBITDA for today is 16.42.

The historical rank and industry rank for Veerhealth Care's EV-to-EBITDA or its related term are showing as below:

BOM:511523' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0.09   Med: 12.33   Max: 126.99
Current: 16.42

During the past 13 years, the highest EV-to-EBITDA of Veerhealth Care was 126.99. The lowest was 0.09. And the median was 12.33.

BOM:511523's EV-to-EBITDA is ranked worse than
57.69% of 735 companies
in the Drug Manufacturers industry
Industry Median: 14.1 vs BOM:511523: 16.42

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-02), Veerhealth Care's stock price is ₹14.99. Veerhealth Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.010. Therefore, Veerhealth Care's PE Ratio (TTM) for today is 1,499.00.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Veerhealth Care EV-to-EBITDA Historical Data

The historical data trend for Veerhealth Care's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veerhealth Care EV-to-EBITDA Chart

Veerhealth Care Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.26 5.50 9.33 9.45 20.70

Veerhealth Care Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.13 20.70 23.79 22.82 21.96

Competitive Comparison of Veerhealth Care's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Veerhealth Care's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veerhealth Care's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Veerhealth Care's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Veerhealth Care's EV-to-EBITDA falls into.


;
;

Veerhealth Care EV-to-EBITDA Calculation

Veerhealth Care's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=291.817/17.774
=16.42

Veerhealth Care's current Enterprise Value is ₹291.8 Mil.
Veerhealth Care's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹17.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veerhealth Care  (BOM:511523) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Veerhealth Care's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14.99/0.010
=1,499.00

Veerhealth Care's share price for today is ₹14.99.
Veerhealth Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.010.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Veerhealth Care EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Veerhealth Care's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Veerhealth Care Business Description

Traded in Other Exchanges
N/A
Address
J.S.S. Marg, Near Kalbadevi Post Office, 629-A, 1st Floor, Gazdar House, Mumbai, MH, IND, 400 002
Veerhealth Care Ltd is an India-based pharmaceutical company. It is engaged in the business of trading and manufacturing and marketing research-based Ayurvedic medicines. It operates in a single segment namely Ayurved Pharma Products.

Veerhealth Care Headlines

No Headlines